InvestorsHub Logo
icon url

ExtremelyBullishZig

12/15/20 8:31 AM

#287740 RE: biotechnician #287738

Why not...two more trials to go...9 to 12 months to revenue...more dilution needed to keep those trials going and maintain 2 years operating expenses in the bank.

Smart people sold on the 7's and 8's and are already increasing their share counts before the market opens.
icon url

Turner2017

12/15/20 8:34 AM

#287744 RE: biotechnician #287738

Based on the results in this first of its kind U.S. Phase 2 (ANAVEX®2-73-RS-001)2 study in adult patients with Rett syndrome, Anavex is planning to meet with FDA to discuss the approval pathway. There are no FDA-approved drugs for Rett syndrome. ANAVEX®2-73 has Fast Track designation, Rare Pediatric Disease designation and Orphan Drug designation from the FDA for the treatment of Rett syndrome and may be considered for accelerated approval.

icon url

Cbdpotential

12/15/20 8:59 AM

#287770 RE: biotechnician #287738

I thought I was a hoarder... now I’m beginning to THINK I’m “a genius” and can’t wait to buy more long term storage units ;-)
Sell!? Thats like watching a soccer match that’s 0-0 for generations and then when a team scores for the first time in history! one decides to leave the arena? I understand there’s some PTSD here from past scientific achievements going unrecognized but, I believe it’s important for one, more than ever, to focus on the long term - step back and see the big picture here again before acting.
Proof of concept just broke the surface.
As long as the science continues .. I’ll be a shareholder till I die ... and setting up a trust for beyond. ;-)